GENOME ANNOUNCEMENT
===================

An increasing number of pertussis-like cases in the United States and Europe are attributed to the emergent pathogen *Bordetella holmesii* ([@B1], [@B2]). An analysis of the 2010-2011 outbreak in Ohio showed that *B. holmesii* was detected in nearly 20% of pertussis-like illnesses ([@B1]), up from \~1% in the 1990s ([@B3], [@B4]). Only three whole-genome sequences are available for this group of pathogens ([@B5][@B6][@B7]). *B. holmesii* genomes do not encode known *Bordetella pertussis* virulence factors, though they share a genomic island that contains the IS*481* insertion element ([@B7]) commonly used to diagnose *B. pertussis* infections and leading to common misidentifications. More specific diagnostic tests were developed using the *B. holmesii*-specific IS*1001* element ([@B4]), but it is unclear whether this marker is sufficient due to sparse genomic data.

Here, we report the genome sequences of 9 clinical isolates obtained between 2004 and 2011: six from patients with bacteremia (five from blood and one from synovial fluid) and three respiratory isolates from patients with pertussis-like symptoms. A respiratory isolate was from an infant who had a coinfection with *B. pertussis*. Genomic DNA was prepared ([@B8]) and sequenced using a combination of 3- or 5-kb mate-pair (\~30× coverage) and 100-bp Illumina paired-end reads (\~50× coverage). After quality trimming, all reads were used in assemblies with Celera Assembler 6.1 ([@B9]) or Velvet Assembler. Underlying consensus sequences and gaps were improved using custom scripts. All genomes had between 119 and 213 contigs ([Table 1](#tab1){ref-type="table"}). The overall G+C content was \~62.6%, with genome sizes ranging from 3.55 Mb to 3.59 Mb.

###### 

Isolate characteristics and accession numbers

  *B. holmesii* isolate ID   State           Yr isolated   Source              Genome length (bp)   Total no. of contigs   GenBank accession no.
  -------------------------- --------------- ------------- ------------------- -------------------- ---------------------- ------------------------------
  H572                       Colorado        2010          Synovial fluid      3,585,459            119                    [JFZY00000000](JFZY00000000)
  H585                       Minnesota       2010          Blood               3,587,402            150                    [JFZZ00000000](JFZZ00000000)
  H629                       New York        2010          Blood               3,475,248            190                    [JGVZ00000000](JGVZ00000000)
  H635                       California      2010          Respiratory fluid   3,569,022            173                    [JGAA00000000](JGAA00000000)
  H643                       Pennsylvania    2010          Blood               3,614,976            193                    [JGWD00000000](JGWD00000000)
  H719                       Minnesota       2011          Blood               3,578,998            149                    [JGWA00000000](JGWA00000000)
  H785                       Oregon          2011          Respiratory fluid   3,565,090            161                    [JGWB00000000](JGWB00000000)
  H809                       New York        2011          Blood               3,584,230            153                    [JMGZ00000000](JMGZ00000000)
  04P3421                    Massachusetts   2004          Respiratory fluid   3,595,240            213                    [JGWC00000000](JGWC00000000)

*B. holmesii* isolates belonged to the same multilocus sequencing type (MLST), as seen in *B. pertussis* strains ([@B10]), suggesting that the *B. holmesii* isolates were also clonal. The genomes were annotated and predicted to have between 3,118 and 3,285 genes. The genomic content of the *B. holmesii* strains was more similar to those of *Bordetella avium* and *Bordetella petrii* than to those of *B. pertussis* or *B. bronchiseptica*. However, nearly 66% of the genes were shared with *B. pertussis* or *Bordetella bronchiseptica*. Almost 400 genes were shared by all *B. holmesii* isolates but were not present in any other bordetellae, likely due to acquisition via horizontal transfer. Many of these genes were involved in the transport and detoxification of organic compounds and antibiotics. Each strain had between 24 and 114 unique genes, including one strain that had residual members of a degraded type III secretion system, as seen in *Escherichia coli* ([@B11]). As expected, the IS*481* element was present in all genomes (32 to 65 copies), as was BhlIS*1001* (5 to 21 copies). The acellular vaccine targets of pertussis toxin, pertactin, and fimbriae were not present, while filamentous hemagglutinin was encoded by all *B. holmesii* genomes.

These findings suggest that circulating *B. holmesii* isolates in the United States emerged from a single genetic background more similar to nonpertussis bordetellae. The genomes are a resource for understanding the pathogenicity and evolution of *B. holmesii* and for further developing detection and differentiation strategies.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The *B. holmesii* whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. described in [Table 1](#tab1){ref-type="table"}. The version described in this paper is the first version.
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